Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT00963040Not ApplicableCompleted

Effect of Intranasal Oxytocin on Headache in Chronic Daily Headache

Role: lead

NCT00812214Phase 4Completed

Treatment of Insomnia in Migraineurs

Role: lead

NCT00930943Phase 4Completed

Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning

Role: lead

All 3 trials loaded